Answers are grounded in this paper and cite their sources.
Hepatocellular Carcinoma (HCC) involves abnormal cholesterol metabolism and evasion of ferroptosis. The HMGCR-mediated Mevalonate (MVA) pathway is a key regulatory hub in both processes. Given the efficacy of Danlou Tablets (DLT) in metabolic dysfunction-associated steatotic liver disease and the inflammation-cancer transformation theory, this study investigates the potential inhibitory effects of DLT on HCC and its underlying mechanisms. Network pharmacology was used to identify the shared targets among DLT, HCC, ferroptosis, and cholesterol synthesis. Bioinformatics analysis based on public databases was performed to explore the clinical significance of HMGCR in patients with HCC. In parallel, UPLC/ESI-Q TRAP-MS/MS was employed to identify the active components of DLT, and molecular docking was subsequently conducted to evaluate their binding affinity to HMGCR. Using Western Blot (WB) and transfection assays, we systematically validated the activation of the MVA pathway, alterations in cholesterol synthesis, and the occurrence of ferroptosis in both clinical HCC tissues and in vitro cell models. We aimed to establish whether DLT could regulate the HMGCR-mediated MVA pathway, which modulates cholesterol synthesis and ferroptosis, thereby potentially inhibiting HCC progression. UPLC/ESI-Q TRAP-MS/MS analysis identified 1,003 components in DLT. In DLT-containing serum, 87 components were upregulated and 22 were downregulated. Molecular docking revealed that eight components may exert therapeutic effects that are partly dependent on HMGCR. In clinical HCC tissues, WB and qRT-PCR assays demonstrated aberrant activation of the HMGCR-mediated MVA pathway, accompanied by accelerated cholesterol synthesis and suppressed ferroptosis. In vitro experiments, including flow cytometry, wound healing assay, and colony formation assays, confirmed that DLT significantly inhibited HCC cell proliferation and migration. WB and qRT-PCR further showed that DLT inhibited cholesterol synthesis and promoted ferroptosis in HCC cells. Mechanistic studies using WB and transfection assays confirmed the critical role of the HMGCR-mediated MVA pathway in DLT-induced HCC inhibition. HMGCR overexpression reversed the DLT-induced inhibition of the MVA pathway in HCC cells, thereby restoring cholesterol synthesis and suppressing ferroptosis mediated by the MVA pathway. DLT may regulate the HMGCR-mediated MVA pathway, modulating cholesterol synthesis and ferroptosis in HCC cells and ultimately suppressing HCC development.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: